H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 8.3% of adults in Irvine have diagnosed diabetes — 3.7 points below the U.S. 12% figure. Census population 307,670. California Medicare wound biologics: Noridian Healthcare Solutions (JE). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Irvine clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Irvine storefront.
Platelet Rich Plasma (PRP) Therapy in Irvine, CA for clinics & physicians. PRP therapy systems with 1-minu… Compliance support & pricing — contact Hawk Medical.
If a sales sheet cannot tell you that Irvine is JE (Noridian Healthcare Solutions) and that adult diabetes here is 8.3% (PLACES 2023), it is selling units, not a program. That is the platelet rich plasma therapy conversation we actually have.
National Platelet Rich Plasma (PRP) Therapy notes (how the product actually works)Three grains, kept separate on purpose. City: Census 307,670 and CDC PLACES crude rates. State: California Department of Public Health, Diabetes Belt not in the core list. Federal: 21 CFR 1271 and Noridian Healthcare Solutions LCDs. CDC PLACES (2023, crude) estimates 8.3% of adults in Irvine have diagnosed diabetes — 3.7 points below the U.S. 12% figure.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Irvine trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 8.3% of adults in Irvine have diagnosed diabetes — 3.7 points below the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 8.3% of adults — 3.7 points below the U.S. 12% figure. Obesity is 19.2%; arthritis is 14.1%. That is place-level BRFSS modeling, not a clinic census and not a Irvine trial.
No. Hematogel is a PRP-based wound gel pathway with its own application and documentation. Skin substitutes/CTPs follow Noridian Healthcare Solutions CTP articles. Mixing those codes is a billing error.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a California compliance risk.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
Bring specialty, monthly joint / regenerative volume, and whether you bill JE FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 8.3% diabetes and 14.1% arthritis for Irvine — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Irvine, CA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Irvine is JE geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Irvine — 3.7 points below the U.S. 12% figure. Planning input, not an outcomes claim.
California Part B wound biologics follow this contractor (siblings: HI, NV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Irvine. Useful for joint-program math; still needs a diagnosis and privileging.
No Irvine storefront. Joe Bradley is an active practice owner. platelet rich plasma therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.